HCV Forum's Treatment Associated Drug Resistance Surveillance & Pharmacovigilance Meeting

E-mail Print

On March 21, 2017 in Amsterdam the HCV Forum hosted a lunch meeting for members to have an informal dialogue about HCV surveillance/pharmacovigilance of DAA treatment associated resistance around the world. The focus of the meeting was to discuss the needs, gaps, opportunities for collaboration and the role of the HCV Forum.

 

Materials